Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

77 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Dacetuzumab, a humanized mAb against CD40 for the treatment of hematological malignancies.
Khubchandani S, Czuczman MS, Hernandez-Ilizaliturri FJ. Khubchandani S, et al. Curr Opin Investig Drugs. 2009 Jun;10(6):579-87. Curr Opin Investig Drugs. 2009. PMID: 19513947
Neutrophils contribute to the biological antitumor activity of rituximab in a non-Hodgkin's lymphoma severe combined immunodeficiency mouse model.
Hernandez-Ilizaliturri FJ, Jupudy V, Ostberg J, Oflazoglu E, Huberman A, Repasky E, Czuczman MS. Hernandez-Ilizaliturri FJ, et al. Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):5866-73. Clin Cancer Res. 2003. PMID: 14676108
Multimodality therapy for thymic carcinoma (TCA): results of a 30-year single-institution experience.
Hernandez-Ilizaliturri FJ, Tan D, Cipolla D, Connolly G, Debb G, Ramnath N. Hernandez-Ilizaliturri FJ, et al. Am J Clin Oncol. 2004 Feb;27(1):68-72. doi: 10.1097/01.coc.0000046301.83671.09. Am J Clin Oncol. 2004. PMID: 14758136
Pro-apoptotic therapy with the oligonucleotide Genasense (oblimersen sodium) targeting Bcl-2 protein expression enhances the biological anti-tumour activity of rituximab.
Ramanarayanan J, Hernandez-Ilizaliturri FJ, Chanan-Khan A, Czuczman MS. Ramanarayanan J, et al. Br J Haematol. 2004 Dec;127(5):519-30. doi: 10.1111/j.1365-2141.2004.05239.x. Br J Haematol. 2004. PMID: 15566355
Rituximab in combination with fludarabine chemotherapy in low-grade or follicular lymphoma.
Czuczman MS, Koryzna A, Mohr A, Stewart C, Donohue K, Blumenson L, Bernstein ZP, McCarthy P, Alam A, Hernandez-Ilizaliturri F, Skipper M, Brown K, Chanan-Khan A, Klippenstein D, Loud P, Rock MK, Benyunes M, Grillo-Lopez A, Bernstein SH. Czuczman MS, et al. J Clin Oncol. 2005 Feb 1;23(4):694-704. doi: 10.1200/JCO.2005.02.172. J Clin Oncol. 2005. PMID: 15681517 Clinical Trial.
Immunomodulatory drug CC-5013 or CC-4047 and rituximab enhance antitumor activity in a severe combined immunodeficient mouse lymphoma model.
Hernandez-Ilizaliturri FJ, Reddy N, Holkova B, Ottman E, Czuczman MS. Hernandez-Ilizaliturri FJ, et al. Clin Cancer Res. 2005 Aug 15;11(16):5984-92. doi: 10.1158/1078-0432.CCR-05-0577. Clin Cancer Res. 2005. PMID: 16115943
Development of targeted therapies for B-cell non-Hodgkin lymphoma and multiple myeloma.
Hernandez-Ilizaliturri FJ, Gowda A, Czuczman MS. Hernandez-Ilizaliturri FJ, et al. Clin Adv Hematol Oncol. 2004 Sep;2(9):606-18. Clin Adv Hematol Oncol. 2004. PMID: 16163245 Review.
Concurrent administration of granulocyte colony-stimulating factor or granulocyte-monocyte colony-stimulating factor enhances the biological activity of rituximab in a severe combined immunodeficiency mouse lymphoma model.
Hernandez-Ilizaliturri FJ, Jupudy V, Reising S, Repasky EA, Czuczman MS. Hernandez-Ilizaliturri FJ, et al. Leuk Lymphoma. 2005 Dec;46(12):1775-84. doi: 10.1080/17402520500182329. Leuk Lymphoma. 2005. PMID: 16263581
Clinical efficacy of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia: results of a phase II study.
Chanan-Khan A, Miller KC, Musial L, Lawrence D, Padmanabhan S, Takeshita K, Porter CW, Goodrich DW, Bernstein ZP, Wallace P, Spaner D, Mohr A, Byrne C, Hernandez-Ilizaliturri F, Chrystal C, Starostik P, Czuczman MS. Chanan-Khan A, et al. J Clin Oncol. 2006 Dec 1;24(34):5343-9. doi: 10.1200/JCO.2005.05.0401. Epub 2006 Nov 6. J Clin Oncol. 2006. PMID: 17088571 Clinical Trial.
Augmented antitumor activity against B-cell lymphoma by a combination of monoclonal antibodies targeting TRAIL-R1 and CD20.
Maddipatla S, Hernandez-Ilizaliturri FJ, Knight J, Czuczman MS. Maddipatla S, et al. Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4556-64. doi: 10.1158/1078-0432.CCR-07-0680. Clin Cancer Res. 2007. PMID: 17671142
77 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback